兽医支架市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球兽医支架市场价值为 4,500 万美元，预计到 2034 年将以 6.7% 的复合年增长率增长至 8,530 万美元。由于对微创治疗的需求不断增长、宠物主人意识的不断提高以及兽医医疗保健的不断进步，市场正在不断扩大。随着全球宠物数量的不断增加，对先进、微创治疗方案的需求也在增加，以确保更快的康復和更少的併发症。支架材料和放置技术的改进等技术创新正在彻底改变小动物的护理，特别是那些需要精确手术才能获得长期功能的动物。

这些发展，特别是在支架中使用镍钛合金和生物相容性聚合物，显着改善了动物呼吸、血管和泌尿疾病的治疗。兽医专业人员现在能够处理复杂病例，风险更低，恢復结果更可预测，使支架植入手术得到更广泛的接受。随着增强型萤光透视和内视镜技术的普及，兽医医院和诊所现在更有能力提供这些程序，从而促进全科诊所和专科中心的更广泛采用。

2024 年，气道支架领域以 1,770 万美元的市场规模领先。这种主导地位与小型犬种呼吸系统疾病的日益普及有关，尤其是气管塌陷（一种导致气道变窄的疾病）。支架设计的新进展，包括自膨胀形式和可生物降解的选择，有效地满足了小动物的独特需求，最大限度地减少了不适和併发症。随着宠物主人和兽医越来越青睐微创治疗，对气道支架的需求持续上升。

2024年，狗类市场占据60.5%的市占率。狗更容易被诊断出患有气道塌陷、血管阻塞和尿道阻塞等慢性疾病，这确保了对兽医支架的稳定需求。大型犬种通常需要血管或泌尿支持，而小型犬和玩具犬种则面临更频繁的呼吸道相关併发症，从而推动了这些产品的使用。

2024 年，北美占据了 41.5% 的市场份额，这得益于宠物拥有量的普及、宠物健康意识的增强以及对先进兽医治疗的日益增长的倾向。该地区拥有强大的兽医基础设施，包括配备最先进的诊断和介入工具的专科医院和急诊中心。熟练的专业人员和先进的影像技术（例如透视和 CT 扫描）进一步提高了支架放置的准确性。

市场的主要参与者包括 Dextronix、EpiicVet、AbtVet（Stening Group）、MI Tech、Infiniti Medical、UltraVet Medical Devices、Create Medic 和 TaeWoong Medical。这些公司正在推动支架设计的创新，特别是针对不同物种和情况的自膨胀和可生物降解材料。与兽医诊所和大学合作进行临床试验和培训有助于品牌扩大其市场影响力，而与分销商建立策略合作伙伴关係、直接联繫兽医以及对数位行销和远距医疗的投资则加强了其在市场中的地位。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 宠物拥有量不断上升
    • 呼吸系统和泌尿系统疾病的盛行率
    • 宠物健康和医疗支出意识不断增强
  • 产业陷阱与挑战
    • 兽医支架和手术费用高昂
    • 支架相关併发症的风险
• 成长潜力分析
• 监管格局
• 技术格局
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 气道支架
• 血管支架
• 尿道支架
• 其他支架

第六章：市场估计与预测：按动物，2021 - 2034 年

• 主要趋势
• 狗
• 猫
• 其他动物

第七章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 气道塌陷
• 血管阻塞
• 尿路阻塞
• 其他应用

第八章：市场估计与预测：按材料，2021 - 2034 年

• 主要趋势
• 镍钛合金
• 可生物降解聚合物

第九章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 兽医医院和诊所
• 其他最终用途

第十章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：公司简介

• AbtVet (Stening group)
• Create Medic
• Dextronix
• EpiicVet
• Infiniti Medical
• MI Tech
• TaeWoong Medical
• UltraVet Medical Devices

The Global Veterinary Stents Market was valued at USD 45 million in 2024 and is estimated to grow at a CAGR of 6.7% to reach USD 85.3 million by 2034. The market is expanding due to the rising demand for minimally invasive treatments, growing awareness among pet owners, and ongoing advancements in veterinary healthcare. As the global pet population continues to increase, so does the need for advanced, less-invasive treatment options that ensure quicker recovery and fewer complications. Technological innovations, such as improvements in stent materials and placement techniques, are revolutionizing care for small animals, especially those requiring precision in surgeries for long-term functionality.

These developments, particularly the use of nitinol and biocompatible polymers in stents, have significantly improved the treatment of respiratory, vascular, and urinary conditions in animals. Veterinary professionals are now able to manage complex cases with fewer risks and more predictable recovery outcomes, making stenting procedures more widely accepted. With better access to enhanced fluoroscopic and endoscopic technology, veterinary hospitals and clinics are now more capable of providing these procedures, fostering broader adoption among general practices and specialized centers.

The airway stents segment led the market with USD 17.7 million in 2024. This dominance is linked to the increasing prevalence of respiratory issues in smaller dog breeds, particularly tracheal collapse, a condition that narrows the airway. New advancements in stent design, including self-expanding formats and biodegradable options, are effectively addressing the unique needs of small animals, minimizing both discomfort and complications. As pet owners and veterinarians increasingly favor less-invasive options, the demand for airway stents continues to rise.

In 2024, the dogs segment accounted for 60.5% of the market share. Chronic conditions such as airway collapse, vascular blockages, and urethral obstructions are more commonly diagnosed in dogs, ensuring steady demand for veterinary stents. Larger dog breeds often require vascular or urinary support, while smaller and toy breeds face more frequent airway-related complications, driving the use of these products.

North America represented 41.5% of the market share in 2024, supported by widespread pet ownership, heightened pet health awareness, and a growing inclination toward advanced veterinary treatments. The region benefits from a robust veterinary infrastructure, including specialty hospitals and emergency care centers equipped with state-of-the-art diagnostic and interventional tools. The availability of skilled professionals and advanced imaging techniques, such as fluoroscopy and CT scans, further enhances the accuracy of stent placement.

Key players in the market include Dextronix, EpiicVet, AbtVet (Stening Group), M.I. Tech, Infiniti Medical, UltraVet Medical Devices, Create Medic, and TaeWoong Medical. These companies are driving innovation in stent design, particularly with self-expanding and biodegradable materials tailored for various species and conditions. Collaborations with veterinary clinics and universities for clinical trials and training are helping brands expand their market presence, while strategic partnerships with distributors, direct outreach to veterinarians, and investments in digital marketing and telemedicine are strengthening their positions in the market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising pet ownership
    • 3.2.1.2 Prevalence of respiratory and urological disorders
    • 3.2.1.3 Growing awareness of pet health and healthcare expenditure
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of veterinary stents and procedures
    • 3.2.2.2 Risk of stent-related complications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Porter’s analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Airway stents
• 5.3 Vascular stents
• 5.4 Urethral stents
• 5.5 Other stents

Chapter 6 Market Estimates and Forecast, By Animal, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Dogs
• 6.3 Cats
• 6.4 Other animals

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Airway collapse
• 7.3 Vascular obstructions
• 7.4 Urinary tract obstructions
• 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Nitinol
• 8.3 Biodegradable polymer

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Veterinary hospitals and clinics
• 9.3 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Italy
  • 10.3.5 Spain
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 AbtVet (Stening group)
• 11.2 Create Medic
• 11.3 Dextronix
• 11.4 EpiicVet
• 11.5 Infiniti Medical
• 11.6 M.I. Tech
• 11.7 TaeWoong Medical
• 11.8 UltraVet Medical Devices